Exercise for Alcohol Use Disorder (Alc-Excr Trial)

N/A

Recruiting

Led By Jesus Chavarria, Ph.D.

Research Sponsored by Western University, Canada

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Inclusion Criteria: Heavy social alcohol drinkers (i.e., alcohol drinkers who consume 10-40 standard alcohol beverages per week and participate in 1-5 binge drinking episodes [consume 4+/5+ drinks in a sitting for women/men, respectively]) per week.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up mid-intervention (32 minutes after prime dose consumption) & post-intervention (44 minutes after prime dose consumption)

Awards & highlights

No Placebo-Only Group

Summary

This trial will study if exercise can reduce alcohol cravings in heavy drinkers & how it affects drink consumption.

Who is the study for?

This trial is for heavy social drinkers who have between 10-40 standard drinks weekly and engage in binge drinking. Participants should be those who typically consume four or more (women) or five or more (men) drinks in one sitting.

What is being tested?

The study is testing if walking on a treadmill, which is mild-to-moderate exercise, can help reduce the craving for alcohol and decrease the consumption of an alcohol-like placebo compared to doing a distracting activity like coloring.

What are the potential side effects?

Since this trial involves exercise and coloring as interventions, there are minimal expected side effects. Exercise may cause physical fatigue or muscle soreness, while coloring is not associated with any known side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I drink 10-40 alcoholic drinks weekly and have 1-5 binge drinking sessions.

Select...

N/A

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ mid-intervention (32 minutes after prime dose consumption) & post-intervention (44 minutes after prime dose consumption)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~mid-intervention (32 minutes after prime dose consumption) & post-intervention (44 minutes after prime dose consumption)

This trial's timeline: 3 weeks for screening, Varies for treatment, and mid-intervention (32 minutes after prime dose consumption) & post-intervention (44 minutes after prime dose consumption) for reporting.